Adoptive immunotherapy offers great potential for treating many types of cancer but its clinical application is hampered by cross-reactive T cell responses in healthy human tissues, representing serious safety risks for patients. | Expitope A tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues